U.S. Banks Stock News

In March 2026, Bio-Techne expanded its COMET spatial biology portfolio with new SPYRE Focus Panels, SPYRE Amplification Kits, and upgraded HORIZON image analysis software to enhance automated, modular tissue analysis workflows from assay design through interpretation. This expansion deepens Bio-Techne’s footprint in high-content spatial biology by combining validated, modular antibody panels with seqLA-based signal amplification to help researchers extract richer insights from scarce tissue...

Nelnet, Inc. recently entered into a new Credit Agreement for a US$435 million unsecured line of credit maturing on March 31, 2031, while terminating its prior US$495 million facility that was due in 2026 and carried no outstanding balance at the time. This refreshed, long-dated borrowing capacity, backed by customary financial covenants and subsidiary guarantees, underscores the company’s emphasis on maintaining flexible funding for general corporate purposes. With this extended US$435...

In March 2026, ICON plc and Advarra announced a partnership to create a connected, “research-ready” site network that links ICON’s clinical trial solutions with Advarra’s widely used site technologies to reduce administrative friction, speed up study startup, and expand trial access globally. This collaboration gives ICON access to Advarra’s data and AI-driven operational intelligence, potentially refining protocol design, forecasting, and site selection by aligning studies more closely with...

Key performance context for PayPay PayPay (PAYP) has drawn attention after a 10.37% one day decline and an 8.81% drop over the past week, prompting investors to reassess its fundamentals and recent share price moves. The company reports annual revenue of ¥355,530 and net income of ¥111,208, with revenue growth of 16.82% and net income growth of 5.77% in the most recent year, all in its reporting currency. See our latest analysis for PayPay. The recent 10.37% one day share price return decline...

Why Maase Has Caught Investor Attention Recent trading interest in Maase (MAAS) has pushed the stock into focus, with short term performance and fundamentals prompting investors to reassess how this US listed China based financial services platform fits into their portfolios. See our latest analysis for Maase. At a share price of $5.90, Maase has seen a 7 day share price return of 8.26% and a 90 day share price return of 13.24%, suggesting recent momentum is building after a relatively modest...

FIHL stock moves and recent financial snapshot Fidelis Insurance Holdings (FIHL) has seen its share price show modest short term moves, with a 1 day return of 0.78% and a past month return of 3.6%. These recent moves may prompt some investors to take a closer look at its fundamentals. The company reports annual revenue of US$2,500.5m and net income of US$225.5m. This implies a net margin figure that investors can compare with other insurers. Annual revenue growth is reported at 11.7%, with...

If you are wondering whether Watts Water Technologies is priced attractively at its recent levels, the starting point is understanding what the current market price is implying about its future. The share price recently closed at US$287.95, with returns of 1.5% over 7 days, a 5.9% decline over 30 days, 3.4% year to date, 58.6% over 1 year, 87.8% over 3 years, and 151.1% over 5 years. Recent coverage of the company has focused on its role within capital goods and water-related solutions. This...

In recent months, the Pennsylvania Public Utility Commission held public hearings and suspended UGI Utilities’ proposed natural gas distribution rate increase, which sought an 8.05% rise in annual operating revenues and would have lifted typical residential bills by about 8–9% to fund infrastructure, cybersecurity, and IT upgrades. This regulatory pushback highlights how strongly public sentiment and oversight can influence UGI’s ability to recover investment spending through higher rates, a...

Immunovant (IMVT) is back in focus after reporting that two Phase 3 studies of batoclimab in thyroid eye disease did not meet their primary endpoint, prompting a shift in attention toward its IMVT-1402 program. See our latest analysis for Immunovant. Despite the batoclimab setback, Immunovant’s recent 1-day and 7-day share price returns of 1.59% and 5.69% suggest some near term optimism. Its 72.97% 1-year total shareholder return keeps the longer term story firmly in focus. If you are...

Chesapeake Utilities Corporation recently reshaped its leadership team, with longtime CFO Beth Cooper set to retire in June 2026 and COO Jeff Sylvester designated as her successor, while Michael Galtman moved to chief transformation officer and Melissa Barnes was appointed vice president and chief accounting officer to lead key finance and reporting functions. These appointments concentrate deep industry and regulatory experience around Chesapeake Utilities’ major finance, transformation and...

Marex Group plc recently issued earnings guidance for the quarter ended March 31, 2026, expecting revenues between US$667,000,000 and US$697,000,000, compared with US$467,000,000 in the same period last year. Management’s expectation of record quarterly profitability, supported by elevated market volatility, growing client balances, and AI-driven margin initiatives, offers a clearer view of how its business model responds when trading conditions become more active. We’ll now examine how this...

Innodata Inc. recently entered a fourth amendment to its credit agreement with Wells Fargo, boosting its secured revolving credit facility to up to US$50,000,000 and extending the maturity to April 4, 2029, while also presenting at Maxim Group’s “Powering the AI Revolution” virtual conference on April 7, 2026. The expanded borrowing base, estimated at about US$30,000,000 as of December 31, 2025, signals a push to support anticipated growth with new and existing AI data customers, reinforcing...

Genco Shipping & Trading recently told shareholders it had rejected Diana Shipping’s US$23.50‑per‑share takeover proposal as offering an insufficient control premium, while reaffirming its plan to remain a low‑leverage, high‑dividend dry bulk carrier and highlighting a five‑year total shareholder return of more than 200% versus major benchmarks. At the same time, Genco has continued expanding its fleet with the delivery of the scrubber‑fitted Newcastlemax vessel Genco Valkyrie, reinforcing...

Nexstar Media Group has recently completed a private fixed-income offering of US$1.73 billion in 7.250% senior unsecured notes due April 15, 2034, using the proceeds to redeem its 5.625% senior notes maturing in 2027 and to cover related fees and expenses. This refinancing reshapes Nexstar’s capital structure by extending debt maturities and adding guarantees and covenants that aim to enhance creditor protections and financial flexibility. Next, we’ll examine how Nexstar’s large 2034 senior...

Earnings and board changes put Kingsoft Cloud Holdings (KC) in focus Kingsoft Cloud Holdings (NasdaqGS:KC) is back on investor radars after releasing its fourth quarter and full year 2025 results, along with a leadership reshuffle that includes the departure of long-time chairman Lei Jun. See our latest analysis for Kingsoft Cloud Holdings. The earnings release and leadership changes came after a period where momentum had already been building, with a 24.15% 90 day share price return and a...

Cinemark Holdings stock moves after recent performance data Cinemark Holdings (CNK) has drawn fresh attention after recent return figures, with the stock showing gains over the past week, month and past 3 months that stand out within the media sector. See our latest analysis for Cinemark Holdings. At a share price of $30.13, Cinemark Holdings has seen short term momentum build, with a 30 day share price return of 8.97% alongside a 1 year total shareholder return of 18.65% and a 3 year total...

RLJ Lodging Trust (RLJ) has drawn investor attention after its share price closed at US$7.26, with recent returns over the past month and past 3 months showing pressure on the stock. See our latest analysis for RLJ Lodging Trust. Short term momentum has been soft, with a 7 day share price return of 3.46% and a 30 day share price return of 7.40%. However, the 1 year total shareholder return of 18.70% shows that longer term holders have still come out ahead despite a 5.10% year to date share...

Investors who take an interest in Epsilon Energy Ltd. ( NASDAQ:EPSN ) should definitely note that the President, Jason...

Investors may be wondering whether Archrock's current share price matches its underlying value, or if the recent buzz has pushed it ahead of itself. The stock recently closed at US$34.90, with a 1.2% move over the past week, a 1.2% decline over the past month, and returns of 31.1% year to date and 67.2% over the last year, while the 3 year and 5 year returns are described as very large. Recent coverage has focused on Archrock as an energy infrastructure company, with attention on how its...

In early April 2026, Tripadvisor announced it had fully repaid its 0.25% Convertible Senior Notes due 2026 at maturity for US$345.40 million in cash and, days earlier, disclosed that Chief Legal Officer and Secretary Seth Kalvert would step down in May 2026 while remaining available in an advisory capacity. Together with a recent cooperation agreement giving activist investor Starboard Value board representation, these moves highlight Tripadvisor’s shifting governance and capital priorities...

Governance shifts put Fortune Brands Innovations (FBIN) under the spotlight Recent governance activity at Fortune Brands Innovations (FBIN) is drawing attention. Shareholders are considering bylaw changes to remove supermajority voting, declassify the board, and address proposals to move all directors to annual elections. See our latest analysis for Fortune Brands Innovations. At a share price of US$37.74, Fortune Brands Innovations has seen its momentum cool, with a 30 day share price return...

If you are wondering whether Bank of New York Mellon Corporation’s recent share price makes sense, the key question is whether you are paying a fair price for the earnings and assets you are getting. The stock last closed at US$123.63, with returns of 7.3% over the past week, 7.3% over the last 30 days, 5.6% year to date and 70.4% over the past year, as well as 197.1% over three years and 190.0% over five years. Recent market attention on BNY has focused on its role as a major custodian bank...

Why Ambarella’s New AI Platforms Are Getting Attention Ambarella (AMBA) is drawing fresh interest after launching its CV7 chip and Cooper Developer Platform, which aim to support edge AI, cloudless robotics orchestration, and machine vision across industrial automation, robotics, and automotive uses. See our latest analysis for Ambarella. Despite the recent product news, Ambarella’s 1-year total shareholder return of 22.39% contrasts with a weaker 90-day share price return of a 36.76%...

Investors may be wondering if Sarepta Therapeutics at around US$22.80 is starting to look interesting again, or if the risks still dominate the story. The stock has recently posted an 11.3% return over 7 days and 36.4% over 30 days, although the 1-year return sits at a 56.5% decline and the 3-year return at an 83.8% decline, with a 67.1% decline over 5 years and a 7.0% return year to date. These moves have put Sarepta back on many watchlists as investors reassess the balance between long...